CORRELATION OF DIASTOLIC BLOOD PRESSURE WITH HIGH SENSITIVITY C- REACTIVE PROTEIN IN MIDDLE AGED CORONARY HEART DISEASE PATIENTS
Main Article Content
Keywords
Blood pressure, Diastolic, Patients, Biomarkers, Inflammatory
Abstract
Introduction: Coronary heart disease (CHD) remains one of the leading causes of morbidity and mortality worldwide, particularly affecting middle-aged individuals. This study aims to explore the correlation between diastolic blood pressure and high-sensitivity C-reactive protein levels in middle-aged patients with coronary heart disease.
Methodology: This cross-sectional study was conducted at Rashid Latif Medical College, Lahore during June 2023 to January 2024. The study involved a sample of 320 patients diagnosed with CHD, recruited from a cardiology clinic. Patients aged 40-60 years, diagnosed with CHD, and willing to provide informed consent were included in the study. A comprehensive medical history was obtained from each patient, including demographic information, lifestyle factors, and clinical history related to CHD. Blood pressure measurements were taken using a calibrated sphygmomanometer.
Results: The study involved 320 middle-aged patients with coronary heart disease (CHD). The mean diastolic blood pressure (DBP) among the participants was 85.2 ± 10.4 mmHg, while the mean serum high-sensitivity C-reactive protein (hs-CRP) level was 3.8 ± 1.6 mg/L. A Pearson’s correlation analysis was conducted to explore the relationship between DBP and hs-CRP levels. The analysis revealed a moderate positive correlation between DBP and hs-CRP levels (r = 0.45, p < 0.001), suggesting that higher DBP is associated with higher levels of hs-CRP.
Conclusion: There is a significant association between diastolic blood pressure and high-sensitivity C-reactive protein levels in middle-aged patients with coronary heart disease
References
2. Ebong IA, Schreiner P, Lewis CE, Appiah D, Ghelani A, Wellons M. The association between high-sensitivity C-reactive protein and hypertension in women of the CARDIA study. Menopause. 2016;23(6):662–8.
3. Tangvarasittichai S, Pingmuanglaew P, Tangvarasittichai O. Association of Elevated Serum Lipoprotein(a), inflammation, oxidative stress and chronic kidney disease with hypertension in non-diabetes hypertensive patients. Indian J Clin Biochem. 2016;31(4):446–51.
4. Haleem, N., Zahra, M., Awan, A. N., Abbasi, S., Taimur, A., & Khan, M. (2024). CORRELATION OF DIASTOLIC BLOOD PRESSURE WITH HIGH SENSITIVITY C-REACTIVE PROTEIN IN MIDDLE AGED CORONARY HEART DISEASE PATIENTS. Pakistan Journal of Physiology, 20(2), 3-7.
5. Liu, Y., Yao, Y., Tang, X. F., Xu, N., Jiang, L., Gao, Z., ... & Yuan, J. Q. (2020). Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology, 75(1), 60-65.
6. Bisaria, S., Terrigno, V., Hunter, K., & Roy, S. (2020). Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension. Journal of Primary Care & Community Health, 11, 2150132720984426.
7. He, L., Fan, C., & Li, G. (2022). The relationship between serum C-reactive protein and senile hypertension. BMC Cardiovascular Disorders, 22(1), 500.
8. Nafari, A., Mohammadifard, N., Haghighatdoost, F., Nasirian, S., Najafian, J., Sadeghi, M., ... & Sarrafzadegan, N. (2022). High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study. BMC Cardiovascular Disorders, 22(1), 241.
9. Kelesoglu, S., Yilmaz, Y., & Elcık, D. (2021). Relationship between C-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease. Angiology, 72(9), 829-835.
10. Burger, P. M., Koudstaal, S., Mosterd, A., Fiolet, A. T., Teraa, M., van der Meer, M. G., ... & Dorresteijn, J. A. (2023). C-reactive protein and risk of incident heart failure in patients with cardiovascular disease. Journal of the American College of Cardiology, 82(5), 414-426.
11. Yang, X., Yang, X., Yang, J., Wen, X., Wu, S., & Cui, L. (2023). High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease. J Epidemiol Community Health, 77(11), 721-727.
12. Tanaka, M., Imano, H., Kubota, Y., Yamagishi, K., Umesawa, M., Muraki, I., ... & Circs Investigators. (2021). Serum high-sensitivity C-reactive protein levels and the risk of atrial fibrillation in Japanese population: the circulatory risk in communities study. Journal of Atherosclerosis and Thrombosis, 28(2), 194-202.
13. Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., ... & Cleland, J. G. (2020). High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), 91-100.
14. Koosha, P., Roohafza, H., Sarrafzadegan, N., Vakhshoori, M., Talaei, M., Sheikhbahaei, E., & Sadeghi, M. (2020). High sensitivity C-reactive protein predictive value for cardiovascular disease: a nested case control from Isfahan cohort study (ICS). Global Heart, 15(1).
15. Feng, G., Yang, M., Xu, L., Liu, Y., Yu, J., Zang, Y., ... & Zheng, X. (2023). Combined effects of high sensitivity C-reactive protein and triglyceride–glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study. Nutrition, Metabolism and Cardiovascular Diseases, 33(6), 1245-1253.
16. Chevli, P. A., Islam, T., Pokharel, Y., Rodriguez, F., Virani, S. S., Blaha, M. J., ... & Shapiro, M. D. (2022). Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of clinical lipidology, 16(6), 870-877.
17. Quispe, R., Michos, E. D., Martin, S. S., Puri, R., Toth, P. P., Al Suwaidi, J., ... & Elshazly, M. B. (2020). High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. Journal of the American Heart Association, 9(3), e013600.